Skip to main content
OpenTrials
Completed

NCT Number: NCT03960190

Clinical Investigation to Assess the Performance of the Eureka Electric Breast Pump in Mothers Breastfeeding Their Healthy Term Infant

Babies are the best in class in order to get human milk out of a lactating breast. With this in mind, Philips has developed the a new electric breast pump, attempting to mimic the babies sucking behavior. The new electric breast pump includes a new vacuum profile and 2 new expression kits.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Philips Innovation Site Eindhoven

Eindhoven, 5656 AE, Netherlands

About this study

Breast pumps currently on the market function by applying vacuum directly to the breast. The effect of a build-up of pressure within the breast due to the accumulation of milk, combined with the external negative pressure introduced by the breast pump, results in the expression of milk. However, in order to express sufficient amounts of milk it is important to stimulate the Milk Ejection Reflex (MER). The MER, also called letdown, draught ejection, expulsion or pumping reflex, is described as a response of the mammary gland to oxytocin. When the nipple is stimulated, the mother's posterior pituitary gland releases oxytocin into the bloodstream. Upon reaching the breast tissue, oxytocin provokes contraction of cells within the structure of the breast causing milk flow. Without the MER successful breastfeeding or breast milk expression cannot happen. In order to stimulate the MER, Philips has developed 2 new expression kits to better mimic the suckling pattern of an infant.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Have an age between 18 and 50 years
  • Have delivered a healthy, term singleton infant (with birth weight above 2.5kg and at least 37 weeks gestation)
  • Have a baby with an age between 1 and 4 months
  • Exclusively breastfeeding at the time of the study
  • Have signed the Informed Consent form

Exclusion criteria

  • Pregnant at the time of the study
  • Suffer from known side effects (sore nipples, nipple trauma, bruising, engorgement, clogged mammary ducts, lactostasis, mastitis) at the time of the study
  • Suffer from syndrome of Raynaud
  • When providing complementary foods to their baby at the time of the study
  • When providing donor milk and/or formula milk to their baby at the time of the study
  • When having their period at the time of the study
  • When taking oral anticonception at the time of the study

Treatment and study plan

Using Eureka Breast Pump with Expression Kit

Device

Each subject will undergo two expression sessions for single and double electric pumping in randomized order to reduce the variation.

Primary outcomes

  1. Evaluating the performance via percentage of the end milk weight that is expressed during the first 5 minutes after pump start of the Eureka electric breast pump and 1K and 2K expression kits.

    Time frame: 3 months

    The data of the expression sessions will be averaged within each of the single and double pumping regimes.

Secondary outcomes

  1. Evaluating the performance weight of expressed milk at 1-minute intervals of the Eureka electric breast pump and 1K and 2K expression kits.

    Time frame: 3 months

    The data of the expression sessions will be averaged within each of the single and double pumping regimes.

  2. Evaluating the performance via total expression time in minutes of the Eureka electric breast pump and 1K and 2K expression kits.

    Time frame: 3 months

    The data of the expression sessions will be averaged within each of the single and double pumping regimes.

  3. Evaluating the performance of time to first milk ejection reflex (MER) pump in seconds of the Eureka electric breast pump and 1K and 2K expression kits.

    Time frame: 3 months

    The data of the expression sessions will be averaged within each of the single and double pumping regimes.

  4. Evaluating the performance via weight (grams) of expressed milk after full expression session of the Eureka electric breast pump and 1K and 2K expression kits.

    Time frame: 3 months

    The data of the expression sessions will be averaged within each of the single and double pumping regimes.

Sponsors and collaborators

Lead sponsor

Philips Consumer Lifestyle

Industry

Registry information

Acronym: EUREKA

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
May 22, 2019
Registry last updated
Nov 12, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.